secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001437749-24-006219
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Talphera reduces board from 10 to 7; three directors resign; regains Nasdaq bid price compliance
--------------------------------------------------------------------------------

- Directors Richard Afable, Howard Rosen, and Pamela Palmer resigned effective Feb 26-28, 2024, no disagreements.
- Board size reduced from ten to seven directors; committees reconstituted with continuing members.
- Nasdaq notified Talphera on Feb 27 that it regained compliance with $1.00 minimum bid price rule as of Feb 26, 2024.
- Pamela Palmer remains Chief Medical Officer; focus on Niyad registrational study.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/0001437749-24-006219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774924006219/acrx20240229_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer